Generative AI’s Technology Is Not Yet Fully Optimized for Healthcare
Summary
Generative artificial intelligence (AI) faces many growing pains as it seeks its footing. In a recent survey, management consulting firm Bain & Company reveals that the main barriers to generative AI in healthcare are a lack of resources, expertise and regulation, with data access and quality and organizational resistance close behind. The recurring theme across industry studies is that generative AI in healthcare is nascent and needs time to prove its efficacy and to earn public trust. Robust benchmarks will increase confidence. The lesson for technology companies, pharmaceutical firms and healthcare providers considering generative AI in their strategies is that the technology is not yet fully optimized for healthcare. For generative AI to bear fruit, it needs investors, technology, resources, expertise, LLMs trained with healthcare-specific data, and robust guidelines. Ultimately, society needs to be ready for and comfortable with the involvement of generative AI in managing patient health and treatment. The task ahead entails expanding resources and expertise, training models on healthcare-specific data and establishing robust benchmarks. In time, through multiple iterations, generative AI will sharpen its analysis. Developers will fine-tune the benchmarks and criteria used in their models, aligning them with emerging regulatory guidelines. The result will be improved accuracy in diagnoses and recommended treatments. Ethical guidelines and human readiness will shape generative AI use and governance. Regulators are urged to move fast, but doing so too quickly could bring unintended consequences. The same caution applies to technology companies that are eager to earn a profit from their innovations. AI tools that gain FDA approval are setting a precedent for what will become commonplace in the future. The potential downside may be that ethical dilemmas will prompt companies and regulators to reconsider their positions. According to a recent study, Americans have mixed feelings about the use of generative AI in their healthcare. While they are enthusiastic about the potential benefits, most Americans are hesitant to replace their medical professionals with this technology. These sentiments may shift over time as technology matures and regulatory guidelines become more robust.The post Generative AI’s Technology Is Not Yet Fully Optimized for Healthcare first appeared on PYMNTS.com.
Robert F. Kennedy Jr. is starting his presidential candidacy as an independent with a strong showing of 19%, according to the super PAC supporting him. Th…
Pro-crypto RFK Jr. leaves Democrats to campaign for U.S. president as independent
Digital Currencies
Summary
Robert F. Kennedy Jr. is starting his presidential candidacy as an independent with a strong showing of 19%, according to the super PAC supporting him. That’s far behind Biden and Trump.
One of the top items on the Securities and Exchange Commission (SEC) agenda under the leadership of Chair Gary Gensler is changes to Regulation D (Reg D)
Rumors Indicate SEC Amendments to Reg D, Accredited Investor Definition are Near
Investments · Digital Currencies
Summary
One of the top items on the Securities and Exchange Commission (SEC) agenda under the leadership of Chair Gary Gensler is changes to Regulation D (Reg D)
Daniel Maeda with Brazil's CVM said during Rio Innovation Week the regulator plans to explore a regulatory sandbox for use cases of tokenization potential…
Brazilian securities regulator plans sandbox for tokenization in 2024
Lending · Digital Currencies
Summary
Daniel Maeda with Brazil's CVM said during Rio Innovation Week the regulator plans to explore a regulatory sandbox for use cases of tokenization potentially starting in 2024.
The company discloses a restructuring in the wake of its decision to exit services related to MEV-Boost Relay, a type of software used by Ethereum network…
Blocknative Reduces Headcount by Third, After Suspending Work on Relay Project
Blockchain · Digital Currencies
Summary
The company discloses a restructuring in the wake of its decision to exit services related to MEV-Boost Relay, a type of software used by Ethereum network validators.
The former Alameda CEO will “tell you about how she and the defendant stole money customers entrusted to FTX,” a prosecutor said. Defense’s cross-examinat…
What to Expect When Caroline Ellison Takes Stand in Sam Bankman-Fried's Trial
Digital Currencies
Summary
The former Alameda CEO will “tell you about how she and the defendant stole money customers entrusted to FTX,” a prosecutor said. Defense’s cross-examination may get personal.
American Express’ recent technology investments include product development and tech stack enhancements. In the second quarter of 2023, the financial inst…
American Express’ recent technology investments include product development and tech stack enhancements. In the second quarter of 2023, the financial institution increased expenses 23% year over year to $402 million, according to its earnings supplement, with the increase primarily driven by higher technology costs. The $245 billion financial institution’s tech focus continued into the third